StockNews.com Initiates Coverage on Taro Pharmaceutical Industries (NYSE:TARO)

Equities research analysts at StockNews.com started coverage on shares of Taro Pharmaceutical Industries (NYSE:TARO) in a research report issued on Sunday. The brokerage set a “strong-buy” rating on the stock.

Separately, HC Wainwright cut Taro Pharmaceutical Industries from a “buy” rating to a “neutral” rating and set a $43.00 target price for the company. in a research note on Thursday, January 18th.

Taro Pharmaceutical Industries Trading Down 0.1 %

Shares of TARO stock opened at $42.45 on Friday. The firm has a fifty day simple moving average of $42.17 and a 200-day simple moving average of $40.29. The company has a market capitalization of $1.60 billion, a PE ratio of 34.80 and a beta of 0.60. Taro Pharmaceutical Industries has a twelve month low of $26.30 and a twelve month high of $45.76.

Institutional Trading of Taro Pharmaceutical Industries

Hedge funds and other institutional investors have recently bought and sold shares of the company. SG Americas Securities LLC acquired a new position in shares of Taro Pharmaceutical Industries in the 3rd quarter worth approximately $141,000. Bank of New York Mellon Corp boosted its holdings in Taro Pharmaceutical Industries by 1.4% in the third quarter. Bank of New York Mellon Corp now owns 22,223 shares of the company’s stock worth $838,000 after purchasing an additional 307 shares during the period. Strs Ohio increased its stake in Taro Pharmaceutical Industries by 58.8% during the third quarter. Strs Ohio now owns 2,700 shares of the company’s stock valued at $101,000 after purchasing an additional 1,000 shares during the last quarter. Allspring Global Investments Holdings LLC bought a new stake in Taro Pharmaceutical Industries during the third quarter valued at $65,000. Finally, Metis Global Partners LLC acquired a new stake in shares of Taro Pharmaceutical Industries during the third quarter worth $262,000. 91.40% of the stock is owned by institutional investors.

About Taro Pharmaceutical Industries

Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products.